Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000078842

Meso Scale Discovery R-PLEX Human cIAP2 ASYQP
SDP

Catalog No. 5000078842
Encompass

The R-PLEX Human CIAP2 Assay Kit from Meso Scale Discovery is a multiplex immunoassay that measures the levels of cellular inhibitor of apoptosis protein 2 (CIAP2) in human serum plasma and cell culture supernatants This assay utilizes electrochemiluminescence (ECL) detection technology and provides high sensitivity broad dynamic range and requires low sample volume The kit includes a 96-well plate coated with capture antibody detection antibody read buffer wash buffer blocker solutions calibrator and controls This assay allows for the quantitative measurement of CIAP2 which plays a role in inhibiting apoptosis and promoting cell survival

Catalog No. 50-000-78842 Supplier Meso Scale Discovery Supplier No. K1517WR22
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

The R-PLEX Human CIAP2 Assay Kit from Meso Scale Discovery is a multiplex immunoassay that measures the levels of cellular inhibitor of apoptosis protein 2 (CIAP2) in human serum plasma and cell culture supernatants This assay utilizes electrochemiluminescence (ECL) detection technology and provides high sensitivity broad dynamic range and requires low sample volume The kit includes a 96-well plate coated with capture antibody detection antibody read buffer wash buffer blocker solutions calibrator and controls This assay allows for the quantitative measurement of CIAP2 which plays a role in inhibiting apoptosis and promoting cell survival

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.